About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Intelligent Control Approach to Anemia Management | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT00572533

Intelligent Control Approach to Anemia Management

First clinical evaluation of "Smart Anemia Manager" algorithm.

Lead sponsor: University of Louisville•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Louisville

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

The purpose of this single-center study is to test whether "Smart Anemia Manager" algorithm improves Hemoglobin stability compared to standard Anemia Management Protocol. Study site: Kidney Disease Program dialysis facility, University of Louisville, Louisville, KY.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. ages 18 to 80,
•2. receiving dialysis treatment,
•3. receiving or expected to receive ESA treatment,
•4. adequacy of dialysis Kt/V \>= 1.2,
•5. adequate iron stores (Ferritin \> 200 ng/mL, TSat \> 20%).

Exclusion Criteria

•1. life expectancy less than 12 months,
•2. frequent uncontrolled blood loss,
•3. frequent dialyzer clotting,
•4. frequent access related problems,
•5. active infections,
•6. severe cardiac disability,
•7. coronary bypass within three months prior to the study
•8. documented resistance to ESA
•9. bone marrow suppression due to HIV, leukemia, or pharmacologic agents.

Related studies

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, and more

RECRUITINGPhase 3

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

NCT06933472 · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, and more

RECRUITINGPhase 1/2

Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

NCT07224763 · ESRD (End-Stage Renal Disease), Kidney Transplantation, and more

Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension

NCT07033260 · Intradialytic Hypotension, End-Stage Renal Disease Requiring Haemodialysis, and more

Comparative Study of Prognosis and QOL Between APD-RPM and CAPD

NCT05738525 · End-stage Renal Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 13, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment62

Start dateApr 2011

Last updatedDec 13, 2017

Condition

End-Stage Renal Disease

Locations shown

University of Louisville Kidney Disease Program

Louisville, Kentucky

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 13, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions